Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF.
about
Beneficial use of fibroblast growth factor 2 and RGTA, a new family of heparan mimics, for endothelialization of PET prostheses.Polysaccharide microarrays for polysaccharide-platelet-derived-growth-factor interaction studies.RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patientsToward new biomaterials.FGF-1 induces ATP release from spinal astrocytes in culture and opens pannexin and connexin hemichannels.An engineered biopolymer prevents mucositis induced by 5-fluorouracil in hamstersInhibitors of slit protein interactions with the heparan sulphate proteoglycan glypican-1: potential agents for the treatment of spinal cord injury.A Heparin-Mimicking Block Copolymer Both Stabilizes and Increases the Activity of Fibroblast Growth Factor 2 (FGF2).Heparin-Mimicking Polymers: Synthesis and Biological Applications.Recent advances on plasmin inhibitors for the treatment of fibrinolysis-related disorders.Heparin mimicking polymer promotes myogenic differentiation of muscle progenitor cells.Heparin and non-heparin-like dextrans differentially modulate endothelial cell proliferation: in vitro evaluation with soluble and crosslinked polysaccharide matrices.Preparation of a novel functional hydrogel consisting of sulfated glucoside-bearing polymer: activation of basic fibroblast growth factor.Mesoglycan and sulodexide act as stabilizers and protectors of fibroblast growth factors (FGFs).Carrageenans inhibit growth-factor binding.Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression.Heparan sulfate mimetics modulate calpain activity during rat Soleus muscle regeneration.Heparin-like polymer improved healing of gastric and colic ulceration.Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G.Release and subcellular localization of acidic fibroblast growth factor expressed to high levels in HeLa cells.Effect of a dextran derivative associated with TGF-beta1 or FGF-2 on dermal fibroblast behaviour in dermal equivalents.Dextran derivatives modulate collagen matrix organization in dermal equivalent.Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic.RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats.Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymersBenzylaminated dextran-modified hydrogels: A long-term bioactive TGF-β1 carrierPeriodontal reconstruction by heparan sulfate mimetic-based matrix therapy in -infected mice
P2860
Q30625086-B8EA680C-B6E5-41C2-A60B-113F193A64FFQ33237146-E883432A-8F18-48E3-AB7F-4B163FB76015Q33844218-9D075DBD-3628-4A2A-A7F5-73912489C35AQ33957905-8D3A7A3E-DE5B-4238-8F64-E7D5A39F33CAQ34450040-DA88E642-7C97-4223-A367-E2021D82F01CQ35083450-D302190D-8C7A-41BA-80A3-B8C6B28C90D6Q36078175-B6C50B97-3E1E-4504-AA7E-6E4F953E0310Q37330610-F2767E18-2F7B-4B85-A623-F6DB01D29733Q37416889-40F5E943-02BD-40EA-B148-F43764BDFFACQ38198582-0D2490C1-83BC-4DC9-9A1E-ECADCE91BDD0Q39634552-6406F592-263A-4057-9D5C-E0D7AFCD1477Q40752131-4C1EF423-5D45-43E6-8414-4746E517DFB1Q41026319-03187398-CBAF-4484-8B42-B1FC9568E876Q41506336-674FF376-5D1B-4D1E-BDFD-946F9097E1CAQ41578288-6143527B-7B88-4914-B6EA-2B7DE09B8CF9Q42813566-39163F92-F26A-415A-AA71-6B15AB6596F0Q43652290-C80CDCAF-5F86-435F-B955-E28A9C1C334AQ43938099-C6B8022F-261B-48F3-AF85-F5EBBD41F913Q44328417-9F123674-177A-4DAB-B841-DB7E2CCE5354Q44938165-F987B319-DB63-4DA4-92E3-F60987ADE2BFQ45222493-C3658142-52F8-454E-B09F-11465A38A5BCQ51173279-D2C158BC-07AE-4C35-921A-1CDC6298FF21Q51811662-34025DA4-3EEE-4B08-B07D-D2413A6D23BCQ52183204-B7A00901-0ED1-498F-AD9D-D8264D01A7EFQ56963867-2C3CDA41-0107-427F-9B17-509A869F0328Q57694927-DE58F1DB-D79D-45F6-BAAE-DC2BBE05D6CFQ58799277-588CA36A-A550-44E8-B310-73FC9CB9FF40
P2860
Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Derivatized dextrans mimic hep ...... ectors of acidic or basic FGF.
@en
type
label
Derivatized dextrans mimic hep ...... ectors of acidic or basic FGF.
@en
prefLabel
Derivatized dextrans mimic hep ...... ectors of acidic or basic FGF.
@en
P2093
P356
P1476
Derivatized dextrans mimic hep ...... ectors of acidic or basic FGF.
@en
P2093
D Barritault
J Jozefonvicz
T Avramoglou
P304
P356
10.1002/JCP.1041500126
P577
1992-01-01T00:00:00Z